CytomX Therapeutics (CTMX) Climbs 50% Following Pact with Moderna on Collaboration for mRNA-Based Conditionally Activated Therapeutics

January 5, 2023 4:37 PM

CytomX Therapeutics (NASDAQ: CTMX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found